Moderna’s Personalised Cancer Vaccine Could Teach the Immune System to Fight Tumours
A New Direction for Cancer Treatment Cancer treatment may be moving toward something much more personal than standard medicines. Moderna and Merck have reported encouraging Phase 3 results from their personalised mRNA cancer vaccine, known as intismeran autogene, for people with high-risk melanoma. The treatment is designed around the genetic features of an individual patient’s…